Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer (TNBC)

Explore clinical trials studying Triple Negative Breast Cancer (TNBC). Study availability and eligibility vary by location and protocol.

54 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer (TNBC) trial results

Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

NCT05985655

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START San Antonio San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT05706129

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • UNSW Sydney, St Vincent's Hospital Sydney Sydney, Australia
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View Trial Details
Recruiting

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

NCT07705334

Conditions
Adenoma, Advanced or Metastatic Solid Tumors, Breast Diseases, +40 more
Locations
  • SCRI at HCA HealthONE Denver, Colorado, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
View Trial Details
Recruiting

Study of XB010 in Subjects With Solid Tumors

NCT06545331

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +31 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 20 locations
View Trial Details
Recruiting

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

NCT06547840

Conditions
Advanced Endometrial Cancer, Advanced Ovarian Cancer, Breast Diseases, +20 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Edinburgh Cancer Research Centre Edinburgh, United Kingdom
  • Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Cambridge University - Addenbrooke's Hospital London, United Kingdom
View Trial Details
Recruiting

Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer

NCT06768931

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Gansu Cancer Hospital Lanzhou, Gansu, China
  • Dongguan People's Hospital Dongguan, Guangdong, China
  • Sun yat sen university cancer center Guangzhou, Guangdong, China
  • Central Hospital of Guangdong Nongken Zhanjiang, Guangdong, China
View Trial Details

Related conditions